Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Thyroid Neoplasms × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Philadelphia Chromosome 2 Translocation, Genetic 1 Recurrence 1 Pathologic Processes 1 Neoplasms by Histologic Type 1 Leukemia, Myeloid 1 Leukemia 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1

Interventions

selpercatinib 2 repotrectinib 1 pralsetinib 1 pembrolizumab 1 larotrectinib 1 cabozantinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡